Krebiozen
Title: Krebiozen
CAS Registry Number: 9008-19-9
Literature References: A white powder "chemically separated from horses' serum after stimulation of their cell network by the injection of Actinomyces bovis." Claimed to be a lipopolysaccharide. Developed by Stevan Durovic. Used experimentally in the treatment of cancer: Szujewski, J. Am. Med. Assoc. 148, 929 (1952). Quackery Congress Symposium: James F. Holland, "The Krebiozen Story", J. Am. Med. Assoc. 200, 213-218 (1967). See also: W. F. Janssen, Anal. Chem. 50, 197A (1978); G. A. Curt, "Unsound Methods of Cancer Treatment" in Cancer: Principles and Practice of Oncology, V. T. DeVita, Jr. et al., Eds. (J. B. Lippincott, Philadelphia, 4th ed., 1993) pp 2734-2747.

Others monographs:
AkuammineMPTPSelenium OxybromideDaucol
5-HETECizolirtine3-Chloro-2-methyl-1-propeneFelypressin
EsculinCycloheptanoneDSPAOrbifloxacin
4,5-Dichloro-2-octyl-3-isothiazoloneBenoxinatePenciclovirBenzethonium Chloride
©2016 DrugLead US FDA&EMEA